Biggest Drugs Stocks Losers - (NASDAQ:GERN, HLCS, DCTH )

Penny Stock Pick Report alerts investors on Top Stocks that would help investors to generate higher than average returns. Subscribe to FREE Stock Alerts by visiting: http://www.pennystockpickreport.com/
 

Geron Corporation (NASDAQ:GERN) was one of the most active losers as it slipped over 9.98% to close at $5.50 on huge volume of 3.43 million shares after Needham gave the Drug Manufacturers some bad news as it announced that the company was downgraded from Buy to Hold. Geron Corporation is developing therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The Company is advancing telomerase targeted therapies, including an anti-cancer drug and a cancer vaccine, through multiple clinical trials.

Helicos BioSciences Corp. (NASDAQ:HLCS) went down $0.19 or 10.05% to close at $1.70 on a volume of over 723K shares. The stock has a 52-week range of $0.21 to $3.54. So far the stock price jumped over 203% in last six months. Helicos BioSciences Corporation is a life sciences company focused on genetic analysis technologies for the research, drug discovery and clinical diagnostics markets.

Delcath Systems, Inc. (NASDAQ:DCTH) fell 7.14% to close at $4.29 on huge volume of 593K shares. The stock prices went down over 20% after the company announced on Oct 27, 2009 that it intends, subject to market and other conditions, to offer up to 8.5 million shares of its common stock in a registered public offering pursuant to its existing shelf registration statement under the Securities Act of 1933.